Android Apple

Novartis' $2.9 Billion Huntington's Bet Sends PTC Stock Soaring Over 14%

By Yahoo! Finance   |   2 weeks ago
Novartis' $2.9 Billion Huntington's Bet Sends PTC Stock Soaring Over 14%

Novartis invests $2.9 billion in PTC Therapeutics' experimental drug for Huntington's disease, aiming to reduce mutant proteins.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.